Zhejiang Medicine Co., Ltd. (SHA:600216)

Zhejiang Medicine Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 25, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	13,136	15,252	10,281	11,203	16,368	13,033
Market Cap Growth	50.66%	48.35%	-8.23%	-31.56%	25.59%	1.87%
Enterprise Value	11,623	14,305	9,752	10,751	15,886	12,611
Last Close Price	13.66	15.86	10.59	11.36	16.22	12.73
PE Ratio	8.87	13.14	23.93	20.76	15.66	18.17
Forward PE	10.16	10.55	13.58	15.18	12.31	8.94
PS Ratio	1.40	1.63	1.32	1.38	1.79	1.78
PB Ratio	1.17	1.40	1.03	1.15	1.78	1.62
P/TBV Ratio	1.26	1.53	1.16	1.32	2.04	1.79
P/FCF Ratio	15.52	28.55	-	-	83.06	18.07
P/OCF Ratio	8.73	12.47	16.21	21.52	14.40	10.37
EV/Sales Ratio	1.24	1.53	1.25	1.33	1.74	1.72
EV/EBITDA Ratio	4.51	6.42	15.23	9.19	9.09	9.84
EV/EBIT Ratio	6.40	9.49	-	21.95	13.69	16.22
EV/FCF Ratio	13.73	26.78	-	-	80.62	17.48
Debt / Equity Ratio	0.07	0.07	0.08	0.09	0.05	0.12
Debt / EBITDA Ratio	0.31	0.33	1.30	0.71	0.27	0.74
Debt / FCF Ratio	0.94	1.40	-	-	2.42	1.32
Asset Turnover	0.70	0.71	0.62	0.65	0.79	0.70
Inventory Turnover	2.69	2.61	2.69	2.81	3.30	3.03
Quick Ratio	1.91	1.67	1.39	1.40	1.30	1.82
Current Ratio	2.85	2.56	2.26	2.29	2.00	2.66
Return on Equity (ROE)	12.43%	9.79%	2.81%	3.84%	10.28%	8.10%
Return on Assets (ROA)	8.43%	7.09%	-0.09%	2.45%	6.30%	4.66%
Return on Capital (ROIC)	9.87%	8.40%	-0.11%	3.03%	7.78%	5.43%
Return on Capital Employed (ROCE)	15.60%	13.40%	-	4.90%	12.20%	9.10%
Earnings Yield	11.11%	7.61%	4.18%	4.82%	6.39%	5.50%
FCF Yield	6.44%	3.50%	-1.58%	-4.06%	1.20%	5.54%
Dividend Yield	1.10%	-	1.42%	1.50%	2.04%	1.81%
Payout Ratio	11.60%	14.67%	44.67%	65.07%	24.88%	140.26%
Buyback Yield / Dilution	2.03%	0.15%	0.31%	-0.47%	-0.26%	-0.46%
Total Shareholder Return	3.13%	0.15%	1.73%	1.03%	1.78%	1.35%

Updated Oct 24, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.